カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の細胞株開発市場2023-2030：製品・サービス別（試薬・培地、装置）、供給源別（哺乳類、非哺乳類）、細胞株種類別、ソース別、用途別

【英語タイトル】Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV010）・商品コード：GRV23NOV010
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

細胞株開発市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の細胞株開発市場規模は2030年までに100.9億米ドルに達し、2023年から2030年までの年平均成長率は9.81%で拡大すると予測されています。細胞株開発（CLD）市場の拡大を促す主な要因の1つは、特にコロナウイルスの蔓延後、世界中でワクチン生産が増加していることです。新しい医療技術の使用増加や癌罹患率の上昇により、CLD市場にはより魅力的で有利な成長見通しが生まれています。生物製剤分野の拡大と成長も、CLD市場発展の主要な決定要因になるでしょう。

技術的に改良されたCLD治療薬の上市が増加していることも、市場拡大の原動力になるでしょう。例えば、BICOの子会社であるCYTENAは、2021年10月に完全に自動化された安定した細胞株開発のための新しいプラットフォームを発表しました。コスト効率に優れ、より優れたラボの自動化を可能にするこのシステムは、CYTENAのクラス最高のリキッドハンドリング情報と、既存の確立された単一細胞分注技術を統合したもの。BICOのBio Convergence agendaは、抗体治療、遺伝子治療、バイオシミラー製造などの次世代医療サービスの発展へのアクセス可能性の拡大を通じて推進されます。

さらに、2021年7月の医薬品製造に関する最新情報によると、NovartisのEntrestoやBiogenのSpinrazaを含むブロックバスターを含む約20の医薬品が2023年に特許満了を迎えます。先発医薬品の特許切れは、バイオシミラーの誕生をもたらしました。その結果、細胞株開発の必要性が高まっています。したがって、市場成長の原動力となるでしょう。

さらに、提携、拡大、買収などの企業戦略の成長も市場成長の原動力となっています。例えば、ProBioGenとGranite Bioは2022年7月、GMP製造・細胞株開発ソリューションの提供とGranite BioのmAbパイプライン開発の支援を目的に提携しました。同様に、2022年6月、FUJIFILM Corporationは、FUJIFILM Diosynth Biotechnologiesの細胞培養生産能力を改善・拡大するために16億米ドルを投資すると発表しました。さらに、2022年10月、Cytiva社は、先進的なCLDおよびウイルスベクター製造技術の著名なドイツメーカーであるCEVEC Pharmaceuticals社を買収しました。この開発を通じて、CEVECはCytivaがバイオ製造技術におけるリーダー的地位を維持するのに役立ちます。

しかし、研究開発能力を構築するために必要な高額な資本費用と支出は、細胞株開発産業の障壁となるでしょう。

細胞株開発市場レポートハイライト

- 製品別では、試薬・培地セグメントが2022年に43.78%の最大シェアを占めました。コスト集約的な性質と生物製剤の製造における頻繁な使用により、これらのアイテムが最大の収益シェアを占めています。

- 供給源別では、哺乳類細胞株セグメントが2022年に72.62%の最大シェアを占めました。哺乳類細胞株はヒトと同一の複雑なタンパク質を発現することができるため、哺乳類細胞株によってバイオ医薬品が効率的に製造される結果、急速に拡大しています。

- 細胞株の種類別では、生物製剤の製造プロセスや遺伝子活性化、タンパク質相互作用などに広く応用されていることから、組み換え細胞株企業が2022年に31.79%の最大シェアを占めました。

- 用途別では、生物生産部門が2022年に46.30%の最大シェアを占めました。体外研究活動の増加、製品の安全性と有効性に関する懸念、バイオシミラーの需要、細胞療法の需要増加などの要因が、バイオ生産産業を牽引しています。

- 北米が2022年に39.22%と大きなシェアを占めたのは、絶え間ない技術改良の存在に加え、新しい発見がバイオ生産のための新しいプロセスの採用に火をつけたためです。Thermo Fisher Scientific Inc.、Sigma-Aldrich Corporation、American Type Culture Collection (ATCC)など、高品質なCLDサービスを提供するこの地域の研究企業による厳格な活動が成長に寄与しています。

- この市場の主なプレーヤーには、Thermo Fisher Scientific Inc.、Corning Inc.、Lonza、Creative BioLabs.、WuXi PharmaTech、Sartorius AG、Merck KGaA、Advanced Instruments、Berkeley Lights、Danaherなどがあります。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の細胞株開発市場：製品・サービス別ビジネス分析
第5章 世界の細胞株開発市場：供給源別ビジネス分析
第6章 世界の細胞株開発市場：細胞株種類別ビジネス分析
第7章 世界の細胞株開発市場：用途別ビジネス分析
第8章 世界の細胞株開発市場：地域別ビジネス分析
第9章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Patent expiration of blockbuster biologics
3.3.2. Rising demand for monoclonal antibodies
3.3.3. Increasing vaccine production
3.3.4. Technological advancement for the cell line development
3.3.5. Increasing prevalence of cancer
3.3.6. Growing R&D investments in biotechnology sector
3.4. Market Restraint Analysis
3.4.1. Presence of complicated regulatory framework
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product & Services Business Analysis
4.1. Global cell line development market: Product & Services Movement Analysis
4.2. Reagents and media
4.2.1. Reagents and media Market, 2018 – 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market, 2018 – 2030 (USD Million)
4.3.2. Automated Systems
4.3.2.1. Automated Systems Market, 2018 – 2030 (USD Million)
4.3.3. Centrifuges
4.3.3.1. Centrifuges Market, 2018 – 2030 (USD Million)
4.3.4. Bioreactors
4.3.4.1. Bioreactors Market, 2018 – 2030 (USD Million)
4.3.5. Storage equipment
4.3.5.1. Storage equipment Market, 2018 – 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market, 2018 – 2030 (USD Million)
4.4. Accessories and consumables
4.4.1. Accessories and consumables Market, 2018 – 2030 (USD Million)
4.5. Services
4.5.1. Services Market, 2018 – 2030 (USD Million)
Chapter 5. Source Business Analysis
5.1. Global cell line development market: Source Movement Analysis
5.2. Mammalian cell line
5.2.1. Mammalian cell line Market, 2018 – 2030 (USD Million)
5.3. Non-mammalian cell line
5.3.1. Non-mammalian cell line Market, 2018 – 2030 (USD Million)
5.3.2. Insects
5.3.2.1. Insects Market, 2018 – 2030 (USD Million)
5.3.3. Amphibians
5.3.3.1. Amphibians Market, 2018 – 2030 (USD Million)
Chapter 6. Type of Cell Lines Business Analysis
6.1. Global cell line development market: Type of Cell Lines Movement Analysis
6.2. Recombinant cell lines
6.2.1. Recombinant cell lines Market, 2018 – 2030 (USD Million)
6.3. Hybridomas
6.3.1. Hybridomas Market, 2018 – 2030 (USD Million)
6.4. Continuous cell lines
6.4.1. Continuous cell lines Market, 2018 – 2030 (USD Million)
6.5. Primary cell lines
6.5.1. Primary cell lines Market, 2018 – 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Global cell line development market: Application Movement Analysis
7.2. Bioproduction
7.2.1. Bioproduction Market, 2018 – 2030 (USD Million)
7.3. Drug discovery
7.3.1. Drug discovery Market, 2018 – 2030 (USD Million)
7.4. Toxicity testing
7.4.1. Toxicity testing Market, 2018 – 2030 (USD Million)
7.5. Tissue engineering
7.5.1. Tissue engineering Market, 2018 – 2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Global Cell line development market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America cell line development market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. Target Disease Prevalence
8.2.2.5. U.S. cell line development market, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Target Disease Prevalence
8.2.3.5. Canada cell line development market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cell line development market, 2018 – 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Target Disease Prevalence
8.3.2.5. Germany cell line development market, 2018 – 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Target Disease Prevalence
8.3.3.5. UK cell line development market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Target Disease Prevalence
8.3.4.5. France cell line development market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Target Disease Prevalence
8.3.5.5. Italy cell line development market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Target Disease Prevalence
8.3.6.5. Spain cell line development market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Target Disease Prevalence
8.3.7.5. Denmark cell line development market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Target Disease Prevalence
8.3.8.5. Sweden cell line development market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Target Disease Prevalence
8.3.9.5. Norway cell line development market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific cell line development market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Target Disease Prevalence
8.4.2.5. Japan cell line development market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. China cell line development market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. India cell line development market, 2018 – 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Target Disease Prevalence
8.4.5.5. South Korea cell line development market, 2018 – 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Target Disease Prevalence
8.4.6.5. Australia cell line development market, 2018 – 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Target Disease Prevalence
8.4.7.5. Thailand cell line development market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America cell line development market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Target Disease Prevalence
8.5.2.5. Brazil cell line development market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Mexico cell line development market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Argentina cell line development market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. MEA cell line development market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Target Disease Prevalence
8.6.2.5. South Africa cell line development market, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. Saudi Arabia cell line development market, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. UAE cell line development market, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. Kuwait cell line development market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market/PositionShare Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Merck KGaA
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Sartorius AG
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Lonza
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. WuXi PharmaTech
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Advanced Instruments
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Berkeley Lights
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Creative BioLabs
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Corning Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 4 Global Cell line development market by Source, 2018 - 2030 (USD Million)
Table 5 Global Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 6 Global Cell line development market by Application, 2018 - 2030 (USD Million)
Table 7 North America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 8 North America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 9 North America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 10 North America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 11 North America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 12 U.S. Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 13 U.S. Cell line development market by Source, 2018 - 2030 (USD Million)
Table 14 U.S. Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 15 U.S. Cell line development market by Application, 2018 - 2030 (USD Million)
Table 16 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 17 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 18 Canada Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 19 Canada Cell line development market by Application, 2018 - 2030 (USD Million)
Table 20 Europe Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 21 Europe Cell line development market by Source, 2018 - 2030 (USD Million)
Table 22 Europe Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 23 Europe Cell line development market by Application, 2018 - 2030 (USD Million)
Table 24 Europe Cell line development market by Country, 2018 - 2030 (USD Million)
Table 25 UK Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 26 UK Cell line development market by Source, 2018 - 2030 (USD Million)
Table 27 UK Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 28 UK Cell line development market by Application, 2018 - 2030 (USD Million)
Table 29 Germany Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 30 Germany Cell line development market by Source, 2018 - 2030 (USD Million)
Table 31 Germany Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 32 Germany Cell line development market by Application, 2018 - 2030 (USD Million)
Table 33 France Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 34 France Cell line development market by Source, 2018 - 2030 (USD Million)
Table 35 France Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 36 France Cell line development market by Application, 2018 - 2030 (USD Million)
Table 37 Italy Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 38 Italy Cell line development market by Source, 2018 - 2030 (USD Million)
Table 39 Italy Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 40 Italy Cell line development market by Application, 2018 - 2030 (USD Million)
Table 41 Spain Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 42 Spain Cell line development market by Source, 2018 - 2030 (USD Million)
Table 43 Spain Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 44 Spain Cell line development market by Application, 2018 - 2030 (USD Million)
Table 45 Denmark Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 46 Denmark Cell line development market by Source, 2018 - 2030 (USD Million)
Table 47 Denmark Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 48 Denmark Cell line development market by Application, 2018 - 2030 (USD Million)
Table 49 Sweden Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 50 Sweden Cell line development market by Source, 2018 - 2030 (USD Million)
Table 51 Sweden Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 52 Sweden Cell line development market by Application, 2018 - 2030 (USD Million)
Table 53 Norway Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 54 Norway Cell line development market by Source, 2018 - 2030 (USD Million)
Table 55 Norway Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 56 Norway Cell line development market by Application, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Cell line development market by Source, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Cell line development market by Application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Cell line development market by Country, 2018 - 2030 (USD Million)
Table 62 China Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 63 China Cell line development market by Source, 2018 - 2030 (USD Million)
Table 64 China Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 65 China Cell line development market by Application, 2018 - 2030 (USD Million)
Table 66 Japan Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 67 Japan Cell line development market by Source, 2018 - 2030 (USD Million)
Table 68 Japan Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 69 Japan Cell line development market by Application, 2018 - 2030 (USD Million)
Table 70 India Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 71 India Cell line development market by Source, 2018 - 2030 (USD Million)
Table 72 India Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 73 India Cell line development market by Application, 2018 - 2030 (USD Million)
Table 74 South Korea Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 75 South Korea Cell line development market by Source, 2018 - 2030 (USD Million)
Table 76 South Korea Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 77 South Korea Cell line development market by Application, 2018 - 2030 (USD Million)
Table 78 Australia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 79 Australia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 80 Australia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 81 Australia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 82 Thailand Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 83 Thailand Cell line development market by Source, 2018 - 2030 (USD Million)
Table 84 Thailand Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 85 Thailand Cell line development market by Application, 2018 - 2030 (USD Million)
Table 86 Latin America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 87 Latin America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 88 Latin America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 89 Latin America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 90 Latin America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 91 Brazil Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 92 Brazil Cell line development market by Source, 2018 - 2030 (USD Million)
Table 93 Brazil Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 94 Brazil Cell line development market by Application, 2018 - 2030 (USD Million)
Table 95 Mexico Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 96 Mexico Cell line development market by Source, 2018 - 2030 (USD Million)
Table 97 Mexico Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 98 Mexico Cell line development market by Application, 2018 - 2030 (USD Million)
Table 99 Argentina Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 100 Argentina Cell line development market by Source, 2018 - 2030 (USD Million)
Table 101 Argentina Cell line development market by Type of Cell Liner, 2018 - 2030 (USD Million)
Table 102 Argentina Cell line development market by Application, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Cell line development market by Country, 2018 - 2030 (USD Million)
Table 108 South Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 109 South Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 110 South Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 111 South Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 116 UAE Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 117 UAE Cell line development market by Source, 2018 - 2030 (USD Million)
Table 118 UAE Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 119 UAE Cell line development market by Application, 2018 - 2030 (USD Million)
Table 120 Kuwait Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 121 Kuwait Cell line development market by Source, 2018 - 2030 (USD Million)
Table 122 Kuwait Cell line development market By Type of Cell Line, 2018 - 2030 (USD Million)
Table 123 Kuwait Cell line development market by Application, 2018 - 2030 (USD Million)
Table 124 Participant’s Overview
Table 125 Financial Performance
Table 126 Key Companies Undergoing Expansions
Table 127 Key Companies Undergoing Acquisitions
Table 128 Key Companies Undergoing Collaborations
Table 129 Key Companies Launching New Products/Services
Table 130 Key Companies Undergoing Partnerships
Table 131 Key Companies Undertaking Other Strategies

List of Figures

Fig. 1 Market Others process
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Global cell line development market: Product & services outlook and key takeaways
Fig. 16 Global cell line development market: Product & services movement analysis
Fig. 17 Global reagents and media market, 2018 - 2030 (USD Million)
Fig. 18 Global equipment market, 2018 - 2030 (USD Million)
Fig. 19 Global Automated Systems market, 2018 - 2030 (USD Million)
Fig. 20 Global centrifuges market, 2018 - 2030 (USD Million)
Fig. 21 Global bioreactors market, 2018 - 2030 (USD Million)
Fig. 22 Global storage equipment market, 2018 - 2030 (USD Million)
Fig. 23 Global Others market, 2018 - 2030 (USD Million)
Fig. 24 Global Accessories and consumables market, 2018 - 2030 (USD Million)
Fig. 25 Global cell line development market: Source outlook and key takeaways
Fig. 26 Global cell line development market: Source movement analysis
Fig. 27 Global mammalian cell line market, 2018 - 2030 (USD Million)
Fig. 28 Global non-mammalian cell line market, 2018 - 2030 (USD Million)
Fig. 29 Global insects market, 2018 - 2030 (USD Million)
Fig. 30 Global amphibians market, 2018 - 2030 (USD Million)
Fig. 31 Global cell line development market: Type of cell line outlook and key takeaways
Fig. 32 Global cell line development market: Type of cell line movement analysis
Fig. 33 Global recombinant cell lines market, 2018 - 2030 (USD Million)
Fig. 34 Global hybridomas market, 2018 - 2030 (USD Million)
Fig. 35 Global continuous cell lines market, 2018 - 2030 (USD Million)
Fig. 36 Global primary cell lines market, 2018 - 2030 (USD Million)
Fig. 37 Global cell line development market: Application outlook and key takeaways
Fig. 38 Global cell line development market: Application movement analysis
Fig. 39 Global bioproduction market, 2018 - 2030 (USD Million)
Fig. 40 Global drug discovery market, 2018 - 2030 (USD Million)
Fig. 41 Global toxicity testing market, 2018 - 2030 (USD Million)
Fig. 42 Global tissue engineering market, 2018 - 2030 (USD Million)
Fig. 43 Global Others market, 2018 - 2030 (USD Million)
Fig. 44 Global cell line development market: Regional outlook and key takeaways
Fig. 45 North America cell line development market, 2018 - 2030 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. cell line development market, 2018 - 2030 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada cell line development market, 2018 - 2030 (USD Million)
Fig. 50 Europe cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany key country dynamics
Fig. 52 Germany cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France key country dynamics
Fig. 54 France cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 UK key country dynamics
Fig. 56 UK cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Asia-Pacific cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 China key country dynamics
Fig. 69 China cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 India key country dynamics
Fig. 71 India cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 South Korea key country dynamics
Fig. 73 South Korea cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Japan key country dynamics
Fig. 75 Japan cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Australia key country dynamics
Fig. 77 Australia cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Thailand key country dynamics
Fig. 79 Thailand cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Latin America cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Mexico key country dynamics
Fig. 84 Mexico cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 MEA cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait cell line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 96 Market participant categorization
Fig. 97 Cell line development market share analysis, 2022
Fig. 98 Strategy framework

★調査レポート[世界の細胞株開発市場2023-2030：製品・サービス別（試薬・培地、装置）、供給源別（哺乳類、非哺乳類）、細胞株種類別、ソース別、用途別] (コード：GRV23NOV010)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞株開発市場2023-2030：製品・サービス別（試薬・培地、装置）、供給源別（哺乳類、非哺乳類）、細胞株種類別、ソース別、用途別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のカスタム抗体市場2023-2030：種類別（モノクローナル）、サービス別（抗体開発）、ソース別（ネズミ）、用途別、エンドユーザー別、地域別
  • 世界の遺伝子合成市場2023-2030：合成法別（固相合成法、チップ合成法、PCR法酵素合成法）、サービス別、用途別、エンドユーザー別、地域別
  • 世界の遺伝子合成（研究用）市場2023-2030：方法別（固相、チップベース）、研究フェーズ別（前臨床、臨床）、用途別、サービス別、エンドユーザー別
  • アメリカの廃液管理市場2023-2030：カテゴリー別（CWT、オンサイト施設）、廃棄物種類別（家庭、商業）、ソース別、サービス別
  • 世界の中央研究所市場2024-2030：サービス別（遺伝子サービス、バイオマーカーサービス）、エンドユーザー別（製薬企業、バイオテクノロジー企業）、地域別
  • 世界のCRISPR・CAS遺伝子市場2023-2030：製品・サービス別、用途別（バイオメディカル、農業）、エンドユーザー別（バイオテクノロジー、製薬企業）、地域別
  • 世界のマイクロRNA市場2024-2030：製品・サービス別（装置、消耗品）、用途別（癌、感染症）、エンドユーザー別、地域別
  • 世界の間葉系幹細胞市場2023-2030：製品・サービス別、ワークフロー別、種類別、隔離源別、疾患別、用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆